6506--RFQ - Blood, Blood Products and Services In Support of the Nebraska Western-Iowa VA Health Care System.
Closed Solicitation Posted
This opportunity was awarded. See the award notice from .
- Solicitation number
- 36C26326Q1098
- Agency
-
Veterans Integrated Service Network 23
Veterans Health Administration, Department of Veterans Affairs
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 621991 Blood and Organ Banks
- PSC
- 6506 Blood And Blood Products
- Place of performance
- Omaha, Nebraska 68105, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Veterans Affairs Veterans Integrated Service Network 23 seeks an FDA-registered source of blood products and services to support the Omaha VA Medical Center, with proposals due September 22, 2026 (amended from September 20) and questions due September 17.
This is an unrestricted RFQ for a single-award, firm fixed price, five-year IDIQ contract with a base year (October 1, 2026 through September 30, 2027) and four one-year ordering periods. Place of performance is Omaha, Nebraska. The procurement applies Service Contract Labor Standards Act wage rates per Wage Determination 2015-5085 (Revision 30) covering Iowa and Nebraska counties including Douglas County (Omaha).
The contractor must supply leukoreduced red blood cell units, blood components, plasma derivatives, and reference laboratory testing services with CLIA certification. All blood products must be FDA-registered, collected and processed in the United States, and comply with American Association of Blood Banks standards and Title 21 CFR. The contractor shall furnish all personnel, supplies, and facilities necessary to collect, process, store, and deliver human blood components and derivatives. Therapeutic apheresis services must be provided in accordance with written physician orders. The contractor must maintain 24/7/365 delivery capability with expedited STAT delivery within one hour and ASAP delivery within four hours, stock mutually agreed inventory levels, and provide trained staff for donor mobile operations.
Offerors must register in SAM and maintain active FDA Blood Establishment Registration. The procurement incorporates FAR clauses for commercial products and services, including Buy American Act compliance (which applies as "N/A" for commercial items) and requires past performance documentation for three similar contracts. Contractor personnel must comply with VA security and privacy requirements, records management obligations, and mandatory security training. Payment is via electronic funds transfer within 30 days of receipt and acceptance. NAICS 621991, PSC 6506.
Notice text
2 versions
Update #2 · Latest ·
09/20/2026: Amended with Amendment 0001. The due time and date is extended. The new due time and date is as follows:
Offers shall be received no later than 05:00 PM CDT, Tuesday, September 22, 2026. All offers shall be emailed to Joseph.Bennett@va.gov. The subject line of all emails must include RFQ number: 36C26326Q1098
There are no other changes.
09/10/2026: This is a combined synopsis/solicitation for commercial products or commercial services prepared in accordance with the format in Revolutionary FAR Overhaul, FAR Subpart 12, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested and a separate solicitation will not be issued. This solicitation is issued as a Request for Quotation (RFQ). This solicitation is Unrestricted.
This notice follow notices 36C26326Q0861 and 36C26326Q0753
The Omaha VA Medical Center (VAMC) has a requirement for a reliable FDA registered source of blood products and services for the treatment of patients. All products will be used for human administration, blood and blood products are considered domestic end times as they are drawn and processed in the United States of America. All referred patient testing results will be included in treatment of the patient based on clinical presentation. Apheresis services will be provided in accordance with written orders issued by the patient’s ordering physician.
Contractor shall furnish all personnel, supplies, and facilities necessary to collect, process, store, and deliver human blood components and derivatives. The contractor shall supply the blood products and services which are listed on the Price/Cost Schedule.
See attached RFQ 1449 document and other attachments.
All questions shall be received no later than 12:00 PM CT Thursday, September 17, 2026.
All offers shall be received by the CO no later than 05:00 PM CT Sunday, September 20, 2026.
All offers shall be emailed to Joseph.Bennett@va.gov
Emails shall include this RFQ number in the Subject Line: 36C26326Q1098.
Update #1 ·
This is a combined synopsis/solicitation for commercial products or commercial services prepared in accordance with the format in Revolutionary FAR Overhaul, FAR Subpart 12, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested and a separate solicitation will not be issued. This solicitation is issued as a Request for Quotation (RFQ). This solicitation is Unrestricted.
This notice follow notices 36C26326Q0861 and 36C26326Q0753
The Omaha VA Medical Center (VAMC) has a requirement for a reliable FDA registered source of blood products and services for the treatment of patients. All products will be used for human administration, blood and blood products are considered domestic end times as they are drawn and processed in the United States of America. All referred patient testing results will be included in treatment of the patient based on clinical presentation. Apheresis services will be provided in accordance with written orders issued by the patient’s ordering physician.
Contractor shall furnish all personnel, supplies, and facilities necessary to collect, process, store, and deliver human blood components and derivatives. The contractor shall supply the blood products and services which are listed on the Price/Cost Schedule.
See attached RFQ 1449 document and other attachments.
All questions shall be received no later than 12:00 PM CT Thursday, September 17, 2026.
All offers shall be received by the CO no later than 05:00 PM CT Sunday, September 20, 2026.
All offers shall be emailed to Joseph.Bennett@va.gov
Emails shall include this RFQ number in the Subject Line: 36C26326Q1098.
Files
Notice history
| Notice | Type | Posted |
|---|---|---|
| 6506--AWARDED - Blood and Blood Products in Support of the Nebraska Western-Iowa VA Healthcare System | Award Notice | |
| This notice | Solicitation | |
| 6506--SOURCES SOUGHT - Blood, Blood Products and Services In Support of the Nebraska Western-Iowa VA Health Care System. | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 6550--Blood Type IVD Reagents | Veterans Integrated Service Network 22 | No set-aside | |
| Sole Source Notice - Blood and Blood Products | Department of Veterans Affairs | No set-aside | |
| NWI Offsite Pathology Services | Veterans Integrated Service Network 23 | Total Small Business | |
| Q301--New Reference Lab Testing | Legacy VISN 15 | Veterans Integrated Service Network 15 | No set-aside | |
| Q301--Reference and Esoteric Laboratory Testing | Veterans Integrated Service Network 2 | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity